LONDON, U.K. -- While barriers to entry remain high with added scrutiny over cardiovascular and other safety risks, the exponential market growth makes diabetes one of the most attractive opportunities in Pharma.
[source - http://www.firstwordplus.com/therapy_trends_diabetes_kol_... - source]
With this is mind, SMi’s 11th annual Diabetes conference comes at the perfect time to discuss, debate and learn with key industry experts at the heart of Diabetes innovation including GlaxoSmithKline, AstraZeneca, Novo Nordisk, Sanof, The International Diabetes Federation plus many more.
In just over 2 weeks’ time, attendees will hear the latest FDA and EU guidelines. The conference will also aim to:
• Present new EU and FDA guidelines on clinical trials on risk-benefit assessment
• Offer peer to peer networking with industry leaders at the for-front of diabetes drug innovation
• Provide clinical updates on novel GLP1 receptor agonists, and SLGT2 and DPP-4 inhibitors
• Address how to utilise biomarkers and imaging for the development of novel therapies for diabetes
• Discuss new therapeutic targets to reduce hypertension, hyperkalaemia and endothelial inflammation in diabetes
• Teach how to capitalise on the effects of targeting RAAS, CCN2 and CCN3 inhibitors
• Review clinical results from the DEMAND study
Diabetes 2013 will deliver 16 case study presentations from key speakers that include:
• Frederick Tam, Reader in Renal Medicine, Imperial College London
• Peter Feldschreiber, Senior Medical Assessor, MHRA
• Philip Ambery, Director, Clinical Development, Glaxo SmithKline Ltd
• Rebecca Taub, CEO, Madrigal Pharmaceuticals
• Tomas Landh, Director, Strategy and Sourcing Diabetes Research Unit, Novo Nordisk A/S
• Katja Rohwedder, Medical Director, AstraZeneca GmbH
• Nigel Sansom, Senior Manager, NHS National Innovation Centre
• Wim Wientjens, Ambassador, International Diabetes Federation
• Natalia Borinshteyn, Head of Diabetes Prevention and Complications, Sanofi-Aventis SA
• Haya Langerman, Medical Advisor, Merck Sharp & Dohme Ltd
For further details visit http://www.smi-online.co.uk/pharmaceuticals/uk/conference...
Diabetes | 1-2 October 2013
Marriott Hotel. Regents Park London, UK
